Suboxone

Suboxone for coming off 7-OH and kratom synthetics. Induction, low-and-slow dosing, short-taper schedules, and the receptor pharmacology behind the approach.

Hold a CDL, FAA medical, LEO position, armed-security license, or healthcare license? Buprenorphine can trigger licensure-board or regulatory issues separate from whether your direct employer is supportive. Read MAT & Your Professional License before disclosing or starting MAT.

Suboxone is the brand name for buprenorphine/naloxone, one medication for coming off opioid dependence, and the route many people in this community have taken. The other community-validated medication-assisted path is SR-17. Tapering with kratom leaf and cold-turkey with helper meds are the non-MAT paths. This page covers Suboxone: induction, dosing, taper plans, and the challenges of using bupe to come off the synthetic mitragynine derivatives.

Important up front: this site focuses on short-term tapers. The goal is using Suboxone as a structured tool to get from dependence to off opioids entirely. Long-term Suboxone maintenance is also a valid choice and saves lives (see Long-term maintenance further down). This community leans short-taper for pharmacological reasons: 7-OH has a short half-life, is mu-dominant, and clears the body fast. Receptor adaptation from 7-OH is less entrenched than from long-acting full agonists, so a brief structured bupe course bridges through acute withdrawal for a large portion of this community. People coming off the long-acting synthetics (MGM-15, pseudo) or off longer-term extended use are in a different situation; longer protocols or long-term maintenance may be the right fit, though not always.

Two things to know before you sit down with a prescriber:

Many prescribers default to 16 mg or 24 mg on day 1. They’re right about safety. The cost of starting that high is a longer, harder taper later. See The receptor-occupancy case for low doses for the pharmacology.
The “14-day taper” figure isn’t a deadline. For 7-OH-focused tapers in this community, expect 5–14 days depending on your day-1 dose. A few extra days at the bottom is normal pacing. See About taper duration.

Both of these are conversations you can have with your prescriber. Bringing the receptor-occupancy data and the realistic-timeline numbers into that conversation works better than disagreeing without specifics.

📊 Want a day-by-day taper schedule? The Suboxone Taper Calculator builds one from your current dose and target endpoint, at any pace from rapid to slow. For the rapid-taper protocol specifically, see Suboxone Rapid Taper.

The medication

Suboxone is a combination of two medications.

Buprenorphine, a partial agonist at the mu-opioid receptor with high binding affinity. It activates the receptor enough to suppress withdrawal and cravings, but at a “ceiling” below what full agonists deliver.
Naloxone, an opioid antagonist included to deter misuse. It absorbs minimally sublingually but blocks opioids if the medication is injected.

Subutex is the buprenorphine-only version, used for pregnant patients, those with naloxone sensitivity, or the lowest portion of a taper. Buprenorphine does the work in both.

Use COWS or SOWS to time induction

Use your withdrawal score, not the clock. Don’t induct until COWS ≥ 12 (or SOWS ≥ 17), regardless of how many hours it’s been. The full scoring rubrics and self-scoring tips are on the COWS & SOWS Guide. Read it before you induct.

Half-lives as context

Half-life suggests when COWS will climb into induction range. The score itself is what decides if you’re ready.

7-OH alone: short half-life (community-observed effect duration roughly 90 minutes to a couple of hours; no direct human PK published, see 7-OH compound page). Community members hit COWS ≥ 12 in the 12 to 18 hour range.
MGM-15 (also sold as MIT-A or DHM): community-reported effective duration roughly 9–15 hours per dose (no published human PK; see MGM-15 page). Reaching induction-ready COWS takes 36 to 72 hours.
Pseudo (MP): binds tighter than buprenorphine itself (Varadi 2016 reports MP Kᵢ ≈ 0.8 nM vs bupe ~1.5 nM). Receptor occupancy can outlast plasma levels. Closer to fentanyl-induction territory than standard kratom-induction.

If you’ve been on the long-acting compounds and your COWS isn’t climbing past 24 hours, that’s the half-life. Wait it out. Be honest with your prescriber about what you were on. Many providers haven’t heard of MGM-15, pseudo, or MIT-A. If they default to the standard short-acting-opioid playbook for these compounds, induction can fail.

Coverage gaps with bupe

The serotonergic and adrenergic piece. Kratom’s minor alkaloids (paynantheine, speciogynine, corynantheidine, and others) bind serotonin and adrenergic receptors directly (León et al., J Med Chem 2021; Obeng et al., J Med Chem 2020). That’s direct receptor agonism or antagonism. Suboxone is opioid-receptor medication. It doesn’t reach the serotonergic-adrenergic load that drives the wired, anxious, can’t-sleep part of withdrawal. Adjuncts like clonidine, gabapentin, lofexidine, and short-term sleep support can fill that gap (see Helper Medications).

For more on bupe failure modes, see Why Suboxone Might Not Be Working.

Induction the low-and-slow way

This community uses a low-and-slow induction approach. The point is to find the minimum effective dose. Lower starting doses leave less to taper through later, which matters when the goal is a short taper.

Wait until COWS ≥ 12 (or SOWS ≥ 17). See the COWS & SOWS Guide for the scoring rubrics.
Start with 2 mg buprenorphine sublingually. Wait 2 hours. Reassess how you feel.
If you still feel withdrawal symptoms: add another 1 mg. Wait an hour. Reassess.
Repeat 1 mg increases hourly until you feel fine.
Whatever total you landed on is your day 1 dose, and that’s your dose for day 2.
If symptoms worsen at any point during induction, stop. This may be precipitated withdrawal.

Notes on this protocol:

If you’re worried about precipitated withdrawal, start at 1 mg instead of 2 mg. Same protocol otherwise: wait, reassess, titrate up in 1 mg increments. Longer ramp, softer landing if your COWS was borderline.
If symptoms get worse after the first dose, stop and wait it out. That’s the signature of precipitated withdrawal. It’s uncomfortable, and it passes within a couple of hours for most people. Don’t keep dosing through it. Once the worst has eased, you can re-attempt induction.
Be patient with the 2-hour window on the first dose. Bupe takes time to take effect. If you’re at hour 1 with no relief, the first 2 mg isn’t done working yet. You can add 1 mg early if symptoms are intolerable, but waiting closer to the full 2 hours gives the most honest signal of whether you need more.
If you’re in deep precipitated withdrawal and waiting it out isn’t easing it. Emerging evidence suggests more buprenorphine can resolve PWD. The mechanism is full receptor occupancy: PWD happens when bupe displaces residual full agonist while bupe-activation hasn’t yet stabilized signaling. Higher bupe doses fill more receptors and let bupe’s partial-agonist effect take over. A 2025 case report (Laxton, Cureus) describes three sequential 8 mg doses (24 mg total over 24 hours) resolving PWD after standard supportive care had failed. The author notes “growing evidence in the literature that withdrawals precipitated by buprenorphine can and should be treated with increased doses of buprenorphine.” Proceed with serious caution. This is an ED-level intervention in the published case literature. It requires more bupe than most people have at home. Don’t attempt it without clinical guidance. If you’re in deep PWD, calling your prescriber (see Telehealth Providers) or going to an ER is the right move. This note exists so you know there’s a path on the other side of that call.

Community members coming off 7-OH land in the 2 to 8 mg range using this approach. People coming off the long-acting synthetics may need more. The standard clinical protocol starts at 4 mg, which is more than this community needs and harder to taper down from.

Standard induction not working, or worried it won’t? The Bernese method (micro-induction) is an alternative pathway. You start tiny doses of bup (0.2–0.5 mg) while continuing your opioid, and titrate up over 5–10 days, no withdrawal wait. Worth considering for long-acting synthetics (MGM-15, pseudo) or for anyone who’s tried standard induction and gotten precipitated withdrawal.

The receptor-occupancy case for low doses

Buprenorphine binding to mu-opioid receptors doesn’t scale linearly with dose. It saturates fast. PET imaging studies show approximate receptor occupancy by daily dose:

Daily dose	Mu-receptor occupancy
2 mg	~41%
4 mg	~60%
8 mg	~74%
16 mg	~80%
32 mg	~84%

The curve flattens past 8 mg. (De Aquino et al. summarizing Greenwald and follow-up PET imaging studies.)

In practice:

Doubling your dose from 8 → 16 mg adds about 2–4% more receptor coverage and doubles what you have to taper through later.
16 → 24 mg adds another ~2%, plus weeks or months to your taper.
24 → 32 mg is about 1% more coverage for another doubling of the eventual taper burden.

A prescriber who wants to start you at 16 mg “to make sure you’re covered” is trading a small additional safety margin for a longer, harder taper. That cost lands on you, not them, because they’re not the ones doing the taper.

Low-and-slow exists because the dose you start at is the dose you have to come off of, and that math compounds above 8 mg.

If you need 16 mg or more to feel stable, you need 16 mg. The point is finding the minimum effective dose.

Tapering off

Once you’ve found your day 1 dose, decide your taper schedule. Examples are in Suboxone Rapid Taper. The last 0.5 to 1 mg are the hardest part for most people. Slow to 0.5 mg drops or smaller at that point. Some people switch to Subutex (no naloxone) for the lowest portion of the taper.

Things that help during the taper:

The supplements and adjuncts in Vitamins & Supplements can take the edge off the lower-dose portions.
Keep your COWS awareness up. Tracking symptoms during a taper helps you decide when to drop and when to hold.
Don’t redose the compound that brought you here (7-OH, MGM-15, pseudo, or stacked synthetics). That restarts the cycle. Planned kratom-leaf tapering is a separate protocol. See Quit 7-OH with Kratom Leaf.

About taper duration

The “14 days” figure that gets thrown around for Suboxone tapers isn’t a deadline. For people coming off 7-OH (most of this community), tapers land between 5 and 14 days, the same range as the rapid-taper protocol in Suboxone Rapid Taper.

Rough shape, by total day-1 dose:

2–4 mg total → a clean 5–7 day taper
4–8 mg total → 7–10 days
8 mg+ total → 10–14 days. A hold at the lowest dose may help.

The weeks-or-months taper doesn’t fit this community’s experience. That kind comes out of long-term high-dose bupe maintenance, a different starting position than what most people here are tapering from. Short, mu-dominant compounds like 7-OH clear faster, and a bupe course bridges acute withdrawal without entrenching its own dependence the way years of high-dose maintenance can.

Stalling at the bottom or wanting extra time on a particular dose is normal pacing. Dragging a taper out beyond a few weeks “just in case” makes the final drop harder. You’ve spent more time on bupe than the medication’s structural role required, and that dependence has to come off too.

If your prescriber is pushing a longer schedule than makes sense for your dose, ask: “Can we plan a shorter step-down? My total dose is only X mg.” Asking for one or two more days for a comfortable last drop is also reasonable. Both are worth bringing up directly.

Finding a Suboxone prescriber

SAMHSA’s buprenorphine practitioner locator
SAMHSA’s national helpline (1-800-662-HELP)
Telehealth Providers: fact-checked comparison of the major options (QuickMD, Bicycle Health, Ophelia, Workit Health, Boulder Care, and others) with current prices, states served, and which ones explicitly handle kratom or 7-OH.
As of 2023, the X-waiver requirement was eliminated. Any provider with a DEA license can prescribe buprenorphine. Primary care doctors who haven’t prescribed it in the past now can.

Common things to ask your prescriber

Are you familiar with kratom-derivative dependence specifically? (7-OH, MGM-15, pseudo)
Are you open to a low-and-slow induction starting at 2 mg?
Will you let me time the first dose by COWS rather than by hours since last use?
What’s your protocol for longer-half-life opioids if I’ve been on those?
Are you willing to prescribe adjuncts (clonidine, etc.) for the non-opioid symptoms?
Are you supportive of a short taper as the goal, rather than long-term maintenance?

If you can’t get good answers, look for a different prescriber. A prescriber pushing high-dose induction and indefinite maintenance without considering your situation may not be the right fit.

Long-term maintenance

This site is taper-focused. Long-term Suboxone maintenance is also a valid choice and saves lives. If you ended up on Suboxone and decided to stay, that’s a stable outcome. People in stable maintenance live full lives, hold jobs, and raise families. The medication does what it’s supposed to do.

This community leans short-taper for a specific reason: 7-OH responds well to short, structured bupe courses. Short plasma half-life, mu-dominant binding, fast clearance. Receptor adaptation doesn’t entrench the way it does with long-acting full agonists. That’s the pharmacology behind the short-taper approach.

Short tapers don’t work for everyone here. People coming off long-acting synthetics (MGM-15, MIT-A, pseudo), off longer-term extended use, or already established on Suboxone maintenance are in different situations. A different approach may be the right call, though not always.

If long-term maintenance fits your situation better, you have options:

Continue maintenance. Stable life, full functioning, no taper urgency. Maintenance is a treatment outcome on its own terms.
Switch to a long-acting injection. Sublocade or Brixadi (extended-release buprenorphine, monthly) get you off the daily sublingual ritual and the per-day decision-making. For some people, that ritual was the unstable part.
Plan a slow taper when you’re ready. Months or years from now, on your timeline. The taper protocols on this site still apply; they take longer when starting from higher doses.

There is no shame in any of these. The shame framing around long-term MAT is a holdover from less-informed treatment culture. It doesn’t reflect what the medication does, or what stable maintenance looks like.

r/suboxone is a larger and more focused community for long-term maintenance discussion. You’re welcome here regardless of where you are in the process.